Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 09:58:31 - browse：7

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

knowledge

hotspot

WSS

European regulators recommend Amylyx's ALS drug be rejected

HHS suspends federal funding for EcoHealth Alliance

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

There’s no way to know how good AI health technologies are

STAT reporters are Pulitzer Prize finalists for investigative reporting

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Wikipedia

Wikipedia

The need-to-know this morning

Is it time to worry about Moderna?

focus

In age of alternative facts, a scholarly course on calling out crap

Better Therapeutics data on benefit with GLP

Activists slam private health insurers over coverage restrictions

Massive project maps cells in human brain in unprecedented detail

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Humana CEO Bruce Broussard to step down in 2024

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare to cover more brain scans related to Alzheimer’s drugs

23andMe had bad news about my health. I wish a person had delivered it

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

hotspot

As H5N1 spreads in cows, experts warn against drinking raw milk

Nick Jonas talks about managing diabetes along with his career

The United States must get value

ALS treatment from Biogen, Ionis fails in study

European regulators recommend Amylyx's ALS drug be rejected

Lilly’s weekly insulin works as well as daily products, new studies show

focus

knowledge

hotspot

hotspot